Jump to HeaderJump to Main ContentJump to Footer
Michigan State University
MSUTODAY
  • Browse Stories By

    Topics

    Explore stories by subject area

    • Arts and Culture
    • Business and Economy
    • Climate and Environment
    • Education and Learning
    • Engineering, Science and Technology
    • Government and Society
    • Health and Medicine
    • Media and Communications
    • MSU Leadership and Impact
    • Sports and Recreation
    • Student and Campus Experience
    View All Stories

    Collections

    Curated story series

    • Turfgrass
    • Ask the Expert
    • Big Ideas
    • Climate solutions
    • Water at MSU
    • Mobility
    • Spartan Perspectives
    • Student views
    • Graduate voices
    • Faculty voices
    View All Collections

    Featured

    Editor's picks

    • 9 reasons to love being a Spartan

      Aug. 28, 2026

      9 reasons to love being a Spartan

    • NIH awards multi-university team over $4M to improve women’s health

      Sept. 15, 2026

      NIH awards multi-university team over $4M to improve women’s health

MSUTODAY
  • Browse Stories By

< Browse Stories By

Topics

Explore stories by subject area

  • Arts and Culture
  • Business and Economy
  • Climate and Environment
  • Education and Learning
  • Engineering, Science and Technology
  • Government and Society
  • Health and Medicine
  • Media and Communications
  • MSU Leadership and Impact
  • Sports and Recreation
  • Student and Campus Experience
  • View All Stories

Collections

Curated story series

  • Turfgrass
  • Ask the Expert
  • Big Ideas
  • Climate solutions
  • Water at MSU
  • Mobility
  • Spartan Perspectives
  • Student views
  • Graduate voices
  • Faculty voices
  • View All Collections

Featured

Editor's picks

  • 9 reasons to love being a Spartan

    Aug. 28, 2026

    9 reasons to love being a Spartan

  • NIH awards multi-university team over $4M to improve women’s health

    Sept. 15, 2026

    NIH awards multi-university team over $4M to improve women’s health

  • For Media
  • Experts
  • Releases and Statements
  • Sign Up
  • Update Information

Resources

  • A to Z Index
  • Find People
  • Maps
  • Email
  • Student Information System (SIS)
  • D2L
  • Libraries
  • Tech Support
  • MSU Misconduct Hotline
  • Social Media Directory
  • Events Calendar
  • For Media
Michigan State University
MSUToday
  • For Media
  • Experts
  • Releases and Statements
  • Sign Up
  • Update Information
Natural Sciences

Jan. 20, 2026 | Read time 3 min

Ask the expert: The truth about the Ozempic craze 

MSU researcher explains how the drug works — and why it’s so hard to lose weight 
 

By: Bethany Mauger

For years, the weight loss industry has buzzed with the latest craze — Ozempic. It’s in TV commercials with ear-worm jingles. It’s on social media as influencers show off their transformation thanks to the drug. And it’s in rumors that circulate each time a celebrity appears with a new physique.

Ozempic and its counterparts, such as Wegovy, are GLP-1 drugs, a new class of drugs that are changing the game for obesity treatment. No longer are diet and exercise or surgery the only options for someone looking to shed more than a few pounds. With a weekly injection or, more recently, a pill, people have hope that their weight loss journey might finally reach a successful destination.

Gina Leinninger, a Red Cedar Distinguished Professor of physiology in the College of Natural Science, specializes in obesity research. Below, she provides insights on how these drugs work and why losing weight isn’t a simple matter.

What are GLP-1 drugs and how do they work?

Glucagon-Like Peptide-1, or GLP-1, receptor agonists are injections and pills that modulate your appetite. They were initially used for Type 2 diabetes because they make the pancreas secrete more insulin, the hormone that cues your body to take up glucose from the blood. GLP-1 also acts in the gastric system and in the brain to suppress appetite. Together, this makes a powerful combo to manage blood glucose and support weight loss, which is why it is very helpful for treating Type 2 diabetes.

Interestingly, your body naturally produces a little GLP-1, but it is degraded too quickly to be effective. Scientists studied how GLP-1 works to make a more stable version that elicits the same beneficial effects, known as GLP-1 receptor agonists. An agonist is a substance that activates a receptor in the body, essentially turning on a biological signal. This is an important example of how scientific research leads to life-changing treatments for disease.

How long do people take these drugs? Is it possible to stop taking them after losing weight?

One of my colleagues calls them forever drugs. And that’s real. You can only get the benefits if you keep taking them. Once you stop, the weight loss effects reverse within a month. Individuals with heart disease are on medications for the rest of their lives. If we are really going to think about obesity as a disease, we must treat it the same way.

Why is it so hard to lose weight without drugs?

Our bodies have evolved to defend our body weight. Our brains use hormones to determine our energy status, and they modify behavior accordingly. If the brain senses we don’t have enough energy, it promotes eating. If it senses we have too much energy, it might tell us to tamp down on eating a bit. But it’s much better at helping us respond to a caloric deficit than to a caloric surplus. It’s very easy in our modern age to take in more calories than we intend to. Then, when you gain weight, your body’s energy balance shifts and your brain says, let’s defend this weight now. The brain is good at keeping your weight static or letting you gain a few pounds. This was probably helpful back when we were hunters and gatherers and didn’t know where our next meal was coming from.

The other side of the coin is, once you’ve lost weight but then gain some back, your body doesn’t want to defend the lower weight. We’ve seen studies on individuals from the show “The Biggest Loser” where, once the show was over, former contestants gained weight even if they kept exercising two hours a day and maintained their diet. That’s because the brain and the body actively don’t want to keep that weight off.

What about nutrition and exercise? Are they still important?

I think it would be great if we all ate better, not for weight loss but for general health. We recognize it’s important to get our fruits and vegetables. While diet and exercise are still the most widely recommended treatment for obesity, we know that they just often don’t work because individuals’ altered brain chemistry doesn’t allow them to work. We need jump-starters like GLP-1 receptor antagonists. They can help retrain the brain and, along with healthy eating habits and exercise, support long-term weight loss. Maybe you do need to be on the drug forever, but maybe you can go down to a fairly low maintenance dose. The drugs are meant to help individuals develop and maintain healthy habits that support a healthy weight for life.

What do you think about using GLP-1 drugs when you’re not obese?

I don’t love it, particularly because it’s taking some of the market share away from individuals who really do need it to protect their lives. For example, my husband has a heart condition and was prescribed Ozempic to help deal with it because it has really great cardio-protective effects. Yet he couldn’t get it as someone with a known heart condition. The drug was in short supply because of people taking it to lose a few pounds, which could be done with diet and exercise. I understand the temptation, but unless it becomes so widely available that that’s an option, I think these first need to be reserved for the many individuals who genuinely need them. We also need to figure out how to make them more accessible because the drugs currently cost up to $1,000 a month.

Are there long-term side effects of these weight loss drugs?

That’s tricky. It took the industry about 20 years after lap band surgeries were developed before we got enough critical mass of data to see the long-term effects. I think our understanding of the real clinical effects of the GLP-1 receptor agonist is yet to come. That said, they do appear to be very safe by all the profiles that we can tell. I wish no ill will. I hope it continues to be wonderful and positive.

MEDIA CONTACTS

Emilie Lorditch
Natural SciencesEngineering, Science and TechnologyDiseases, Conditions and TreatmentsHealth and MedicineFitness and Exercise

Collection

more content from this collection

Ask the Expert

Latest News

MSUToday Weekly Update

The MSUToday Weekly Update email showcases how Spartans are making a difference through academic excellence, research impact and community outreach. Get inspired by these stories of innovation, collaboration and determination. Plus, enjoy photos and videos of campus and more MSU content to help keep you connected to the Spartan community.

Sign UpUpdate My Information

Connect With Us

Visit our Facebook pageVisit our page on XVisit our Instagram pageVisit our LinkedIn pageVisit our YouTube pageVisit our TikTok page

Health and Safety

  • MSU Police and Public Safety
  • Olin Health Center
  • Counseling & Psychiatric Services (CAPS)
  • University Health and Wellbeing
  • MSU Health Care
  • Civil Rights and Title IX
  • Our Commitment
  • Center for Survivors
  • Security & Fire Safety Report
  • University Policy on Relationship Violence and Sexual Misconduct
  • Notice of Non-Discrimination, Anti-Harassment and Non-Retaliation
  • Health Care Non-Discrimination Notice

Support Services

  • Disability Resources
  • Supportive Services
  • Learning Resources

Working at MSU

  • Human Resources
  • EBS Login
  • Job Postings
  • Employee Assistance Program

Reports

  • CARES Act Funding
  • Student Achievement and Outcomes

Contact us

517-355-1855

Address

Michigan State University 426 Auditorium Road East Lansing, MI 48824

Follow Us

  • Visit our Facebook page
  • Visit our page on X
  • Visit our Instagram page
  • Visit our TikTok page
  • Visit our LinkedIn page
  • Visit our YouTube page

If you're having accessibility issues, please let us know.

Know More: Campus Safety Information and ResourcesTransparency Reporting: Budget & Salary/Compensation
  • Contact Information|
  • Site Map|
  • Privacy Statement|
  • Site Accessibility|
  • Call MSU: (517) 355-1855|
  • Visit: msu.edu|
  • Notice of Nondiscrimination|

SPARTANS WILL|© Michigan State University|